Patrick Machado, Director at Adverum Biotechnologies, Inc. (ADVM), bought 10,000 shares at $11.52 ($115K) on 2021-01-15, disclosed to the SEC on 2021-01-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |
| UROV | BUY | 2019-06-11 | $292K | — | Filing → |
| UROV | BUY | 2019-06-06 | $218K | — | Filing → |